← SynDRA
FORMESTANE
SynDRA canonical compound SYN0004602 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | CYP19A1 |
| Mechanism of action | aromatase inhibitor |
| Indication | breast cancer |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- aromatase inhibitor
- CYP19A1 INHIBITOR
Drug classes
- Antineoplastic Agents
- Aromatase Inhibitors
- Enzyme Inhibitors
- Estrogen Antagonists
- Hormone Antagonists
- Steroid Synthesis Inhibitors
ATC classes
- L02B · HORMONE ANTAGONISTS AND RELATED AGENTS
Cross-references
Synonyms
- lentaron
- Formestano
- 4-oh-androstene-3,17-dione
- CGP-32349
- NSC-282175
- Lentaron
- 4-Hydroxyandrost-4-ene-3,17-dione
- 4-Hydroxyandrostenedione
- CGP 32349
- Lentaron(R)
- 4-OH-A
- B, Aromatase inhibitor
- 4-Hydroxy-4-androstene-3,17-dione
- NSC 282175
- 17-dione
- 4-OHA
- Formestane [INN:BAN]
- UNII-PUB9T8T355
- CCRIS 7483
- ANDROST-4-ENE-3,17-DIONE, 4-HYDROXY-
- 4-Hydroxy-delta(sub 4)-androstenedione
- BRN 1889793
- MLS002153359
- MLS000028826
- PUB9T8T355
- CHEBI:75172
- 4-OHAD
- (8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione
- 4-hydroxy-Delta(4)-androstenedione
- Formestane (INN)
- SMR000058722
- FORMESTANE [INN]
- (8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,6H)-dione
- CAS-566-48-3
- formestano
- formestanum
- SaveCream
Look up FORMESTANE in the interactive SynDRA portal →